Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Checklist of Responsibilities for the Scientific Editor of This Article
Publishing Process of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5798)
All Articles published online
|
Publishing Process of This Article
|
Feb 15, 2017 (publication date) through Dec 11, 2023
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | do Espírito Santo GF, Galera BB, Duarte EC, Chen ES, Azis L, Damazo AS, Saba GT, de Sousa Gehrke F, Guerreiro da Silva IDC, Waisberg J. Prognostic significance of vascular endothelial growth factor polymorphisms in colorectal cancer patients. World J Gastrointest Oncol 2017; 9(2): 78-86 [PMID: 28255429 DOI: 10.4251/wjgo.v9.i2.78] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v9/i2/78.htm |
| Number | Citing Articles |
| 1 |
O. A. Babadjanov, H. Ya. Karimov, S. S. Arifov, K. T. Boboev. Evaluation into the Role of the VEGF Gene Polymorphism rs2010963 in the Development of Rosacea and its Relationship with Clinical Subtypes of the Disease. Cytology and Genetics 2019; 53(3): 233 doi: 10.3103/S0095452719030083
|
| 2 |
Md. Abdul Aziz, Mohammad Sarowar Uddin, Md. Shalahuddin Millat, Mohammad Safiqul Islam. Vascular endothelial growth factor A (VEGFA) promoter rs2010963 polymorphism and cancer risk: An updated meta-analysis and trial sequential analysis. Meta Gene 2022; 31: 101017 doi: 10.1016/j.mgene.2022.101017
|
| 3 |
Giorgia Marisi, Irene Azzali, Alessandro Passardi, Francesca Rebuzzi, Giulia Bartolini, Milena Urbini, Matteo Canale, Chiara Molinari, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Graziana Gallo, Giovanni Luca Frassineti, Paola Ulivi. Prospective validation of VEGF and eNOS polymorphisms as predictors of first-line bevacizumab efficacy in patients with metastatic colorectal cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-40220-7
|
| 4 |
Hong Wu, Tianjun Ma, Dongli Li, Mei He, Hui Wang, Ying Cui. Circulating vascular endothelial growth factor and cancer risk: A bidirectional mendelian randomization. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.981032
|
| 5 |
N. García-Romero, I. Palacín-Aliana, R. Madurga, J. Carrión-Navarro, S. Esteban-Rubio, B. Jiménez, A. Collazo, F. Pérez-Rodríguez, A. Ortiz de Mendivil, C. Fernández-Carballal, S. García-Duque, J. Diamantopoulos-Fernández, C. Belda-Iniesta, R. Prat-Acín, P. Sánchez-Gómez, E. Calvo, A. Ayuso-Sacido. Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. BMC Medicine 2020; 18(1) doi: 10.1186/s12916-020-01610-0
|
| 6 |
Mehtap Cevik, Esat Namal, Nur Dinc-Sener, Ulkuhan Iner-Koksal, Cavlan Ciftci, Belgin Susleyici. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects. Genetic Testing and Molecular Biomarkers 2022; 26(5): 298 doi: 10.1089/gtmb.2021.0213
|
| 7 |
Maria Abancens, Viviana Bustos, Harry Harvey, Jean McBryan, Brian J. Harvey. Sexual Dimorphism in Colon Cancer. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.607909
|
| 8 |
Martha M. Grimes, S. Ray Kenney, Dayna R. Dominguez, Kathryn J. Brayer, Yuna Guo, Angela Wandinger-Ness, Laurie G. Hudson. The R-enantiomer of ketorolac reduces ovarian cancer tumor burden in vivo. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-020-07716-1
|
| 9 |
Reyhaneh Manafi-Farid, Bahar Ataeinia, Shaghayegh Ranjbar, Zahra Jamshidi Araghi, Mohammad Mobin Moradi, Christian Pirich, Mohsen Beheshti. ImmunoPET: Antibody-Based PET Imaging in Solid Tumors. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.916693
|